The Business Times
business-time-50
SUBSCRIBERS

Drugmaker Shire offers to buy Baxalta for US$30b

google-preferred-sourceAdd BT as a preferred source
Published Wed, Aug 5, 2015 · 09:50 PM

London

IRISH drugmaker Shire said on Tuesday that it had offered to buy the biopharmaceutical company Baxalta in an all-stock deal worth about US$30 billion.

Shire said on Tuesday that it had approached Baxalta in early July about a potential combination, but Baxalta concluded, following a written proposal on July 31, not to proceed with discussions.

drugmaker

TRENDING NOW

Previous offers for Automobile Megamart's lease renewal had lapsed as the subsidiary proprietors failed to come to a consensus.

Car dealers submit S$68 million for renewal of Automobile Megamart’s lease

Longest-serving chief minister Taib Mahmud’s legacy looms large over Sarawak as a family feud over his estate threatens to expose skeleton’s in the eastern state’s political closet.

On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart

State-level minimum purchase thresholds push foreign buyers towards higher-value properties, while consent rules and other restrictions further narrow the pool of homes available to them.

That ‘cheap’ Malaysia condo could cost Singapore buyers far more than they think

US President Trump with Chinese President Xi while leaving after a visit to the Zhongnanhai Garden in Beijing on May 15.

Trump leaves Beijing with few wins but warm words for Xi

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More